BRC

Brady is a high-quality niche manufacturer (identification/labeling and safety products) whose financial profile screams durability: 50.3% gross margin, 15.6% operating margin, 15.9% ROE, and a near-pristine balance sheet with liabilities/equity of just 0.45x, $174M cash against only $99.8M long-term debt (net cash positive), and a four-year string of growing revenue ($1.14B→$1.51B FY21-FY25). It returns capital steadily — $50.8M buybacks plus $45.5M dividends in FY2025 — and is reinvesting (R&D +17.9%). This is the kind of consistent, profitable compounder the rubric rewards.

But the FY2025 numbers flash a clear caution: despite revenue rising +12.8%, net income FELL -4.0% (to $189M, below FY2024's $197M peak) and operating income slipped -2.8%, so margins are compressing as the top line grows. The MD&A and Risk Factors explain why — management flags raw-material/cost inflation, higher wage rates, and tariff/trade-policy pressure on input costs, plus the candid admission that competitive pressure may prevent passing those costs through ('we may not be able to pass along increased raw material and component part costs... or our ability to do so could be delayed'). The 36% jump in D&A and 14.4% asset growth alongside revenue suggest acquisition-fueled growth diluting organic profitability, and operating cash flow falling -29% to $181M while cash dropped -30% is a real quality-of-earnings yellow flag worth watching.